Exercise crucial to maintain weight loss after stopping GLP-1 RAs: study
More patients maintained weight loss one year after by combining exercise with pharmacotherapy, researchers find.
The addition of supervised exercise to GLP-1 receptor agonist therapy improves healthy weight maintenance after treatment termination, according to Danish findings.
Researchers from the University of Copenhagen investigated whether weight loss and improved body composition were sustained better with a GLP-1 receptor agonist (RA), a supervised exercise program or both combined for one year after the end of active treatment.
